Login to Your Account



Other News To Note


Tuesday, May 10, 2011
OPKO Health Inc., of Miami, was awarded a grant from the Dravet Syndrome Foundation to support development of potential therapeutics for Dravet syndrome, also called severe myoclonic epilepsy of infancy, a rare genetic disorder that causes a severe form of epilepsy.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription